An AI-powered, virtual platform is being developed to improve care for patients living with genetic disorders, as part of a Digital Health CRC project led by Peter MacCallum Cancer Centre and Swinburne University of Technology.
Evusheld is an extra COVID-19 medication that provides added protection for vulnerable patients. Peter Mac is recommending this medication for patients with blood cancer, or cancer patients who are immunosuppressed.
Brian Le has been appointed to the position of Honorary Clinical Professor in both the Sir Peter MacCallum Department of Oncology and the Department of Medicine – Royal Melbourne Hospital at the University of Melbourne.
Peter Mac’s Associate Professor Belinda Campbell will use a new fellowship to find practical solutions to improve equity of care for patients with cutaneous T-cell lymphomas – no matter where they live in Australia.
Researchers have developed a new blood test that could revolutionise how chemotherapy is used for colon cancer, by identifying the patients that need chemo and those that can be safely spared treatment.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.